# Screening of biomarkers for early diagnosis of trauma-induced coagulopathy based on untargeted metabolomics

## TL;DR

This study identifies two potential biomarkers for early detection of trauma-induced coagulopathy using metabolomics.

## Contribution

The study introduces two novel LysoPE metabolites as highly sensitive and specific biomarkers for early diagnosis of TIC.

## Key findings

- LysoPE(20:4(8Z,11Z,14Z,17Z)/0:0) showed an AUC of 0.933 for distinguishing TIC patients.
- LysoPE(0:0/18:2(9Z,12Z)) had an AUC of 0.916 for TIC detection.
- These metabolites outperformed conventional coagulation tests and admission scores.

## Abstract

Trauma-induced coagulopathy (TIC) is an acute coagulation disorder characterized by massive bleeding following trauma and is a leading cause of mortality. However, current clinical methods are inadequate for predicting TIC onset, and reliable biomarkers for early diagnosis are lacking. This study aimed to identify potential biomarkers with high sensitivity and specificity for TIC using an untargeted metabolomics approach.

We analyzed serum samples from 54 trauma patients (27 with TIC and 27 without TIC) and 27 healthy controls. All samples were collected within 24 hours post-trauma. Metabolomic profiling was conducted using liquid chromatography-tandem mass spectrometry (LC-MS).

Metabolite profiles differed significantly between the TIC and non-TIC groups. Two metabolites, LysoPE(20:4(8Z,11Z,14Z,17Z)/0:0) (AUC = 0.933, 95% CI: 0.849–0.995) and LysoPE(0:0/18:2(9Z,12Z)) (AUC = 0.916, 95% CI: 0.818–0.914), were identified as potential biomarkers for distinguishing TIC. The diagnostic performance of these metabolites surpassed that of both conventional coagulation tests and admission assessment scores.

Two LysoPE metabolites were identified as promising biomarkers for the early detection of TIC.